Hilsenbeck SG - Search Results

1

Molecular profiles of progesterone receptor loss in human breast tumors.

Creighton CJ, Kent Osborne C, van de Vijver MJ, Foekens JA, Klijn JG, Horlings HM, Nuyten D, Wang Y, Zhang Y, Chamness GC, Hilsenbeck SG, Lee AV, Schiff R. Creighton CJ, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 2009 Mar;114(2):287-99. doi: 10.1007/s10549-008-0017-2. Epub 2008 Apr 19. Breast Cancer Res Treat. 2009. PMID: 18425577 Free PMC article.

2

Rising levels of estrogen receptor in breast cancer over 2 decades.

Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM. Pujol P, et al. Among authors: hilsenbeck sg. Cancer. 1994 Sep 1;74(5):1601-6. doi: 10.1002/1097-0142(19940901)74:5<1601::aid-cncr2820740517>3.0.co;2-#. Cancer. 1994. PMID: 8062191

3

Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.

Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D. Rocha RL, et al. Among authors: hilsenbeck sg. J Natl Cancer Inst. 1996 May 1;88(9):601-6. doi: 10.1093/jnci/88.9.601. J Natl Cancer Inst. 1996. PMID: 8609661

4

WAF1/CIP1 protein expression in human breast tumors.

Diab SG, Yu YY, Hilsenbeck SG, Allred DC, Elledge RM. Diab SG, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1997 Apr;43(2):99-103. doi: 10.1023/a:1005752829260. Breast Cancer Res Treat. 1997. PMID: 9131264

5

Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer.

Clark GM, Allred DC, Hilsenbeck SG, Chamness GC, Osborne CK, Jones D, Lee WH. Clark GM, et al. Among authors: hilsenbeck sg. Cancer Res. 1997 Dec 15;57(24):5505-8. Cancer Res. 1997. PMID: 9407959

6

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.

Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW. Lavinsky RM, et al. Among authors: hilsenbeck sg. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2920-5. doi: 10.1073/pnas.95.6.2920. Proc Natl Acad Sci U S A. 1998. PMID: 9501191 Free PMC article.

7

IGF system components as prognostic markers in breast cancer.

Lee AV, Hilsenbeck SG, Yee D. Lee AV, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1998 Feb;47(3):295-302. doi: 10.1023/a:1005915420341. Breast Cancer Res Treat. 1998. PMID: 9516083 Review.

8

Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.

Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng Cn, Lee AV, Yee D. Rocha RL, et al. Among authors: hilsenbeck sg. Clin Cancer Res. 1997 Jan;3(1):103-9. Clin Cancer Res. 1997. PMID: 9815544

9

The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.

Oesterreich S, Hilsenbeck SG, Ciocca DR, Allred DC, Clark GM, Chamness GC, Osborne CK, Fuqua SA. Oesterreich S, et al. Among authors: hilsenbeck sg. Clin Cancer Res. 1996 Jul;2(7):1199-206. Clin Cancer Res. 1996. PMID: 9816288

10

Time-dependence of hazard ratios for prognostic factors in primary breast cancer.

Hilsenbeck SG, Ravdin PM, de Moor CA, Chamness GC, Osborne CK, Clark GM. Hilsenbeck SG, et al. Breast Cancer Res Treat. 1998;52(1-3):227-37. doi: 10.1023/a:1006133418245. Breast Cancer Res Treat. 1998. PMID: 10066085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page